Mutation of either site disrupts BRCA1 promoter activity in ovarian cancer cell lines (Supplementary Fig. 9a), demonstrating that both are required for full transcriptional activation of the BRCA1 promoter in these cells. Here, BRCA1 is linked to ovarian carcinoma.